Litigation Capital Management (LON:LIT) Receives Buy Rating from Canaccord Genuity Group

Litigation Capital Management (LON:LIT)‘s stock had its “buy” rating reissued by analysts at Canaccord Genuity Group in a research report issued to clients and investors on Tuesday,Digital Look reports. They presently have a GBX 182 ($2.31) price objective on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 83.84% from the stock’s current price.

Separately, Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 182 ($2.31) price objective on shares of Litigation Capital Management in a research note on Tuesday.

Litigation Capital Management Price Performance

LIT traded down GBX 1 ($0.01) on Tuesday, hitting GBX 99 ($1.26). 355,949 shares of the company were exchanged, compared to its average volume of 153,328. Litigation Capital Management has a fifty-two week low of GBX 84.50 ($1.07) and a fifty-two week high of GBX 122 ($1.55). The company has a debt-to-equity ratio of 32.77, a quick ratio of 3.01 and a current ratio of 17.54. The firm has a market capitalization of £101.52 million, a P/E ratio of 1,650.00 and a beta of 0.31. The business’s fifty day moving average is GBX 112.12 and its 200 day moving average is GBX 107.51.

Insider Activity

In other news, insider Patrick Moloney sold 75,991 shares of the firm’s stock in a transaction on Monday, October 28th. The stock was sold at an average price of GBX 112 ($1.42), for a total transaction of £85,109.92 ($108,199.75). Insiders own 19.51% of the company’s stock.

About Litigation Capital Management

Litigation Capital Management Limited provides dispute finance and risk management services in Australia and the United Kingdom. The company operates in two business models, including direct investments made from LCM's permanent balance sheet capital; and fund and/or asset management. Its products and services include dispute finance for companies, international arbitration, and law firms; disbursement funding; enforcement funding/purchase of award; and adverse cost and security for costs.